MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ)
$0.015 0.0064 (74.4186%)
Analysed MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) News Sources
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
23-03-2026
yahoo.com
CDT Equity Inc. Announces Reverse Stock Split
25-03-2026
yahoo.com
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
26-03-2026
yahoo.com
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
07-04-2026
yahoo.com
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
16-04-2026
yahoo.com
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
06-05-2026
yahoo.com
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
07-05-2026
yahoo.com
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage
11-05-2026
yahoo.com
CDT Announces Canadian Patent for AZD5904 in Male Infertility
27-05-2026
yahoo.com
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
28-05-2026
yahoo.com
What is the current price of MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ)?
The current price of MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) is $0.015.
MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) absolute price change since previous trading day?
The absolute price change of MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) since the previous trading day is $0.0064.
MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) percentage price change since previous trading day?
The percentage price change of MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) since the previous trading day is 74.4186%.
What is the most recent average sentiment score for MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ)?
The most recent average sentiment score for MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ)?
The most recent sentiment for MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ) is .
SEC-8K** Filing Available For MURPHY CANYON ACQ-CW27 (CDTTW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.